vs
COMPUGEN LTD(CGEN)与Rithm Property Trust Inc.(RPT)财务数据对比。点击上方公司名可切换其他公司
COMPUGEN LTD的季度营收约是Rithm Property Trust Inc.的1.0倍($3.5M vs $3.4M),Rithm Property Trust Inc.净利率更高(95.4% vs -410.1%,领先505.5%),Rithm Property Trust Inc.同比增速更快(-39.7% vs -61.8%)
Compugen是一家处于临床阶段的上市预测药物研发企业,1993年成立,总部位于以色列,最初以计算药物发现服务商身份起家,为制药企业提供软件与计算服务,预测各类生物现象,目前股份同时在纳斯达克资本市场和特拉维夫证券交易所上市交易。
Rithm Property Trust Inc.旗下的里思资本是一家总部位于纽约的美国投资管理公司,核心业务聚焦于房地产投资及另类投资领域,是该赛道颇具影响力的专业投资机构。
CGEN vs RPT — 直观对比
营收规模更大
CGEN
是对方的1.0倍
$3.4M
营收增速更快
RPT
高出22.1%
-61.8%
净利率更高
RPT
高出505.5%
-410.1%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $3.5M | $3.4M |
| 净利润 | $-14.5M | $3.2M |
| 毛利率 | — | — |
| 营业利润率 | -475.1% | 99.6% |
| 净利率 | -410.1% | 95.4% |
| 营收同比 | -61.8% | -39.7% |
| 净利润同比 | -54.7% | 11.2% |
| 每股收益(稀释后) | $-0.16 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CGEN
RPT
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | $3.5M | $4.2M | ||
| Q1 25 | — | $249.0K | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $2.6M | — | ||
| Q3 23 | — | $1.1M | ||
| Q2 23 | $0 | — |
净利润
CGEN
RPT
| Q4 25 | — | $3.2M | ||
| Q3 25 | — | $-273.0K | ||
| Q2 25 | $-14.5M | $1.9M | ||
| Q1 25 | — | $-3.4M | ||
| Q2 24 | $-9.4M | — | ||
| Q1 24 | $7.3M | — | ||
| Q3 23 | — | $-5.5M | ||
| Q2 23 | $-18.6M | — |
毛利率
CGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | 60.5% | — | ||
| Q1 24 | 17.9% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
营业利润率
CGEN
RPT
| Q4 25 | — | 99.6% | ||
| Q3 25 | — | -6.2% | ||
| Q2 25 | -475.1% | 45.7% | ||
| Q1 25 | — | -1416.5% | ||
| Q2 24 | -128.5% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | -533.4% | ||
| Q2 23 | — | — |
净利率
CGEN
RPT
| Q4 25 | — | 95.4% | ||
| Q3 25 | — | -6.8% | ||
| Q2 25 | -410.1% | 45.1% | ||
| Q1 25 | — | -1363.1% | ||
| Q2 24 | -101.4% | — | ||
| Q1 24 | 284.0% | — | ||
| Q3 23 | — | -526.3% | ||
| Q2 23 | — | — |
每股收益(稀释后)
CGEN
RPT
| Q4 25 | — | $-0.26 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | $-0.16 | $0.01 | ||
| Q1 25 | — | $-0.08 | ||
| Q2 24 | $-0.10 | — | ||
| Q1 24 | $89505618.00 | — | ||
| Q3 23 | — | $-0.25 | ||
| Q2 23 | $-0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $35.3M | $79.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $50.3M | $291.6M |
| 总资产 | $106.5M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CGEN
RPT
| Q4 25 | — | $79.3M | ||
| Q3 25 | — | $81.4M | ||
| Q2 25 | $35.3M | $98.6M | ||
| Q1 25 | — | $97.4M | ||
| Q2 24 | $44.6M | — | ||
| Q1 24 | $39.3M | — | ||
| Q3 23 | — | $63.9M | ||
| Q2 23 | $21.6M | — |
股东权益
CGEN
RPT
| Q4 25 | — | $291.6M | ||
| Q3 25 | — | $291.7M | ||
| Q2 25 | $50.3M | $294.7M | ||
| Q1 25 | — | $296.1M | ||
| Q2 24 | $58.3M | — | ||
| Q1 24 | $65.6M | — | ||
| Q3 23 | — | $320.2M | ||
| Q2 23 | $62.0M | — |
总资产
CGEN
RPT
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $106.5M | $1.0B | ||
| Q1 25 | — | $1.0B | ||
| Q2 24 | $110.2M | — | ||
| Q1 24 | $121.3M | — | ||
| Q3 23 | — | $1.4B | ||
| Q2 23 | $77.1M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-18.6M | $-8.3M |
| 自由现金流经营现金流 - 资本支出 | $-18.8M | — |
| 自由现金流率自由现金流/营收 | -530.8% | — |
| 资本支出强度资本支出/营收 | 6.5% | — |
| 现金转化率经营现金流/净利润 | — | -2.56× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CGEN
RPT
| Q4 25 | — | $-8.3M | ||
| Q3 25 | — | $-5.8M | ||
| Q2 25 | $-18.6M | $-25.0K | ||
| Q1 25 | — | $-1.6M | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | $-10.7M | ||
| Q2 23 | $-18.6M | — |
自由现金流
CGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-18.8M | — | ||
| Q1 25 | — | — | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | $-18.6M | — |
自由现金流率
CGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -530.8% | — | ||
| Q1 25 | — | — | ||
| Q2 24 | 428.3% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资本支出强度
CGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | — | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | 0.0% | ||
| Q2 23 | — | — |
现金转化率
CGEN
RPT
| Q4 25 | — | -2.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.01× | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图